Objective The efficiency of cell therapy is limited by poor cell

Objective The efficiency of cell therapy is limited by poor cell engraftment and survival. MSCs viability and mobility and improved their capability to promote endothelial pipe formation in vitro markedly. These results had been paralleled by elevated phosphorylation and nuclear translocation of STAT3. In vivo, JI-34 pre-treatment improved the engraftment of MSCs into ischemic hindlimb… Continue reading Objective The efficiency of cell therapy is limited by poor cell